Waystar Q2 revenue beats analyst expectations

Overview

• Healthcare payment software firm's Q2 revenue rose 18% yr/yr, beating analyst expectations

• Adjusted EPS for Q2 beat analyst expectations

Outlook

• Waystar expects 2026 revenue between $1.276 bln and $1.294 bln

• Company sees 2026 adjusted EBITDA between $535 mln and $545 mln

• Waystar expects 2026 non-GAAP net income between $322 mln and $340 mln

Result Drivers

• PROVIDER ADOPTION - Co said results were driven by growing provider adoption of its platform

• PLATFORM CAPABILITIES - Co cited the breadth of its platform, scale of data, and impact of AltitudeAI as supporting client performance

• SUBSCRIPTION REVENUE GROWTH - Q2 subscription revenue rose 34% yr/yr, outpacing volume-based revenue growth

Company press release: ID:nPn4f3ZW2a

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 23 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the software peer group is "buy"

• Wall Street's median 12-month price target for Waystar Holding Corp is $32.50, about 37.2% above its July 28 closing price of $23.69

• The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 14 three months ago

Reuters Recommended Reads

• July 28 - NRC Health Q2 revenue rises on the back of product innovation

• July 28 - Chemed Q2 revenue beats estimates, helped by VITAS segment growth

• July 29 - Blackbaud Q2 EPS beats estimates on cost discipline

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)